InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
0.00%
)
US TECH 100
19,264.80
(
0.03%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
85.05
(
0.05%
)
Bitcoin
63,642.78
(
-1.82%
)
Post# of 252281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: hptaxis post# 121014

Sunday, 06/05/2011 4:49:46 PM

Sunday, June 05, 2011 4:49:46 PM

Post# of 252281
Vemurafenib as monotherapy result is VERY impressive, much more than IPI in combination with dacarbazine on both efficacy and safety. I know it is not exact same patient population, but comparison will inevitablely made:

HR 0.26 for Vemurafenib vs dacarbazine.
HR 0.72 for Yervoy plus dacarbazine vs dacarbazine.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up